Patents by Inventor Steven Danso

Steven Danso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant butyrylcholinesterases and truncates thereof
    Patent number: 8952143
    Abstract: Isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity are disclosed, along with molecular criteria for preparing such nucleic acids, including codon optimization. Methods of preparing modified and/or truncated BChE molecules having selected properties, especially selective formation of monomers, are also described. Vectors and cells containing and/or expressing the nucleic acids are also disclosed.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: February 10, 2015
    Assignee: PharmAthene, Inc.
    Inventors: Kalvin Yim, Steven Danso, Edward Hausknecht
  • Recombinant Butyrylcholinesterases and Truncates Thereof
    Publication number: 20140220658
    Abstract: Isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity are disclosed, along with molecular criteria for preparing such nucleic acids, including codon optimization. Methods of preparing modified and/or truncated BChE molecules having selected properties, especially selective formation of monomers, are also described. Vectors and cells containing and/or expressing the nucleic acids are also disclosed.
    Type: Application
    Filed: April 3, 2014
    Publication date: August 7, 2014
    Applicant: PharmAthene Inc.
    Inventors: Kalvin Yim, Steven Danso, Edward Hausknecht
  • Recombinant butyrylcholinesterases and truncates thereof
    Patent number: 8729245
    Abstract: Isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity are disclosed, along with molecular criteria for preparing such nucleic acids, including codon optimization. Methods of preparing modified and/or truncated BChE molecules having selected properties, especially selective formation of monomers, are also described. Vectors and cells containing and/or expressing the nucleic acids are also disclosed.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: May 20, 2014
    Assignee: Pharmathene, Inc.
    Inventors: Kalvin Yim, Steven Danso, Edward Hausknecht
  • Recombinant Butyrylcholinesterases and Truncates Thereof
    Publication number: 20120252094
    Abstract: Isolated nucleic acids encoding polypeptides that exhibit butyrylcholinesterase (BChE) enzyme activity are disclosed, along with molecular criteria for preparing such nucleic acids, including codon optimization. Methods of preparing modified and/or truncated BChE molecules having selected properties, especially selective formation of monomers, are also described. Vectors and cells containing and/or expressing the nucleic acids are also disclosed.
    Type: Application
    Filed: December 21, 2010
    Publication date: October 4, 2012
    Inventors: Kalvin Yim, Steven Danso, Edward Hausknecht